Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -111,129 | -124,084 | -123,665 | -72,721 | -38,395 |
| Depreciation Amortization | 8,284 | 9,002 | 6,160 | 3,092 | 2,483 |
| Accounts payable and accrued liabilities | -581 | -3,282 | 1,660 | 8,600 | 142 |
| Other Working Capital | -7,931 | -5,648 | -849 | 4,742 | -234 |
| Other Operating Activity | 20,856 | 21,940 | 12,270 | -4,525 | 557 |
| Operating Cash Flow | $-90,501 | $-102,072 | $-104,424 | $-60,812 | $-35,447 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,139 | 49,979 | 104,274 | -213,443 | 2,753 |
| PPE Investments | -1,025 | -1,239 | -20,630 | -25,121 | -9,763 |
| Other Investing Activity | 17 | -25 | 8 | 0 | 0 |
| Investing Cash Flow | $1,131 | $48,715 | $83,652 | $-238,564 | $-7,010 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 47,749 | 4,550 | 77,767 | 189,002 | 34 |
| Common Stock Repurchased | N/A | N/A | N/A | -13 | -1 |
| Other Financing Activity | 0 | -501 | 0 | 19,981 | 147,235 |
| Financing Cash Flow | $47,749 | $4,049 | $77,767 | $208,970 | $147,268 |
| Beginning Cash Position | 46,363 | 95,671 | 38,676 | 129,082 | 24,271 |
| End Cash Position | 4,742 | 46,363 | 95,671 | 38,676 | 129,082 |
| Net Cash Flow | $-41,621 | $-49,308 | $56,995 | $-90,406 | $104,811 |
| Free Cash Flow | |||||
| Operating Cash Flow | -90,501 | -102,072 | -104,424 | -60,812 | -35,447 |
| Capital Expenditure | -1,025 | -1,239 | -20,630 | -25,121 | -9,763 |
| Free Cash Flow | -91,526 | -103,311 | -125,054 | -85,933 | -45,210 |